The Strategist

The long-term impact of Change hack, plus GLP-1s expand to CV

Posted By The Academy

March 21, 2024

This issue of The Strategist includes:

1. Change is finally back online, as health systems assess fallout

2. FDA approval and new partnerships expand reach of GLP-1 drugs

3. Mark Cuban Cost Plus Drugs partners with CHS

More Posts of Interest

Catalyst Website Images 2
The Strategist
Strategy Catalyst
CVS and Walmart's full-scale virtual primary care: following in Optum's footsteps

June 9, 2022

Read Time - 10 minutes

Catalyst Website Images 2
The Strategist
Strategy Catalyst
Will public takedowns of digital health companies impact LHS?

March 31, 2022

Read Time - 10 minutes

Catalyst Website Images 2
The Strategist
Strategy Catalyst
Walgreens moves more deeply into value-based care as Oak Street receives AARP endorsement

October 29, 2021

Read Time - 10 minutes